Clinical Trial Update: Mineralocorticoid Receptor Antagonists in End Stage Renal Disease [Phase 2]

View source ↗

Summary

Phase 2 trial investigating mineralocorticoid receptor antagonists in end stage renal disease patients on hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hemodialysis

Snippet

Sponsor: Wuerzburg University Hospital | Conditions: End Stage Renal Disease / Hemodialysis | Phase 2 | Status: COMPLETED